Company Noul Co.,Ltd.

Equities

A376930

KR7376930004

Biotechnology & Medical Research

Business Summary

Sales per Business

Sales per region

Managers

Members of the board

Share class

Shareholders

Company contact information

Sector

Sales per Business

Sales per region

Sector Bio Diagnostics & Testing

End-of-day quote Korea S.E. Other stock markets 06:00:00 2024-05-21 pm EDT			5-day change	1st Jan Change
2,705 ^KRW	-5.75%		+6.92%	-33.37%

Apr. 25	Noul Announces 2 Clinical Performance Studies At Pan-African Malaria Conference	CI
2023	Noul Co., Ltd. Unveils the Result of Malaria Study in Ethiopia and Ghana	CI

Noul Co Ltd is a Korea-based company principally engaged in the next generation diagnostic testing platform business. The Company is engaged in the manufacture and sale of blood test diagnostic devices based on the artificial intelligence (AI) algorithms and diagnostic kits. In addition, the Company is also engaged in the provision of services such as regular monthly subscriptions and others through an integrated web-based remote diagnosis system.

KRW in Million	2022	Weight	2023	Weight	Delta
Others 67.9 %	33	6.1 %	1,856	67.9 %	+5,523.88%
Blood Test Diagnostic Device 27.1 %	406	74.9 %	742	27.1 %	+82.71%
Diagnostic Cartridge 5.0 %	103	19.0 %	136	5.0 %	+32.17%

KRW in Million	2022	Weight	2023	Weight	Delta
South Korea 67.7 %	-158	-29.1 %	1,851	67.7 %	-1,274.99%
Africa 29.8 %	505	93.3 %	816	29.8 %	+61.39%
Asia 2.2 %	42	7.7 %	60	2.2 %	+44.58%
Europe 0.3 %	80	14.8 %	7	0.3 %	-91.28%

Managers	Title	Age	Since
Chan-Young Im CEO	Chief Executive Officer	45	15-11-30
Ri-Hyeon Kim DFI	Director of Finance/CFO	42	20-04-30
Dong-Young Lee CTO	Chief Tech/Sci/R&D Officer	45	15-11-30
Jeong-Kwon Ahn BRD	Director/Board Member	45	17-01-31
Kyung-Hwan Kim BRD	Director/Board Member	45	-
Sang-Yeol Shin SAM	Sales & Marketing	53	21-04-30
Won-Jang Ko AUD	Comptroller/Controller/Auditor	53	21-11-30

Members of the board	Title	Age	Since
Chan-Young Im CEO	Chief Executive Officer	45	15-11-30
Dong-Young Lee CTO	Chief Tech/Sci/R&D Officer	45	15-11-30
Kyung-Hwan Kim BRD	Director/Board Member	45	-
Jeong-Kwon Ahn BRD	Director/Board Member	45	17-01-31
Seon-Ji Lee BRD	Director/Board Member	56	21-07-31
Sung-Soo Jung BRD	Director/Board Member	56	-

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	36,947,060	25,284,881 ( 68.44 %)	0	68.44 %

Name	Equities	%	Valuation
mSeed Co. Ltd. 17.46 %	6,452,256	17.46 %	11 M ₩
Dayli Partners Co. Ltd. 5.905 %	2,181,792	5.905 %	4 M ₩
Kyung-Hwan Kim 4.625 %	1,708,686	4.625 %	3 M ₩
Chan-Yang Im 4.122 %	1,523,052	4.122 %	3 M ₩
Premier Partners, LLC 3.910 %	1,444,528	3.910 %	2 M ₩
Dong-Young Lee 1.230 %	454,550	1.230 %	759 721 ₩
Jeong-Kwon Ahn 0.7754 %	286,476	0.7754 %	478 807 ₩
JX Partners Co. Ltd. 0.7305 %	269,892	0.7305 %	451 089 ₩
Noul Co., Ltd.ESOA 0.3613 %	133,495	0.3613 %	223 120 ₩
Mi-jin Kim 0.2114 %	78,104	0.2114 %	130 541 ₩

Noul Co., Ltd.

338 Gwanggyojungang-ro Suji-gu

16942, Yongin-si

http://www.nou.co.kr

Healthcare

Pharmaceuticals & Medical Research

Biotechnology & Medical Research

Biotechnology & Medical Research

Bio Diagnostics & Testing

	1st Jan change	Capi.
NOUL CO.,LTD.	-33.37%	73.17M
EXACT SCIENCES CORPORATION	-27.70%	9.87B
GUARDANT HEALTH, INC.	-16.78%	2.75B
BGI GENOMICS CO., LTD.	-15.31%	2.13B
VERACYTE, INC.	-21.41%	1.65B
MARAVAI LIFESCIENCES HOLDINGS, INC.	+68.70%	1.47B
CAREDX, INC	+29.75%	811M
SEEGENE, INC.	-5.02%	733M
ADAPTIVE BIOTECHNOLOGIES CORPORATION	-29.39%	510M
CURIOX BIOSYSTEMS CO., LTD	+1.59%	300M

Bio Diagnostics & Testing